Management Team

Adam Schechter became chief executive officer of Labcorp (NYSE: LH) in November 2019 and chairman in May 2020. Previously, Schechter was named lead independent director in January 2019 after serving on the board since 2013. Under Schechter’s leadership, Labcorp, a leading global life sciences

Megan Bailey has served as Labcorp’s Executive Vice President and President, Central Laboratory Services and International since 2024. Previously, she served as Labcorp’s Executive Vice President and Chief Strategy and Transformation Officer where she led efforts to define Labcorp’s future growth

In October 2024, Lance Berberian announced his planned retirement from Labcorp in 2025. Lance served as Executive Vice President and Chief Information and Technology Officer from 2014 through October 2024. In November 2024, he stepped into the role of Special Advisor, Strategy.

Brian Caveney, M.D. has served as Executive Vice President and President, Early Development Research Laboratories and Chief Medical and Scientific Officer at Labcorp since 2023. In his current role, Brian leads all early development research laboratories globally and oversees all medical and

In November 2024, Glenn Eisenberg announced his planned retirement from Labcorp, effective April 30, 2025. Glenn served as Executive Vice President and Chief Financial Officer (CFO) since 2014. In December 2024, Glenn assumed the role as Special Advisor to the CEO to ensure a seamless transition of

Anita Graham has served as Executive Vice President and Chief Human Resources Officer since 2023. Before joining Labcorp, Anita served as Executive Vice President, Chief Human Resources Officer and Public Affairs at VF Corporation, one of the world’s largest lifestyle-focused footwear and apparel

Mark Schroeder has served as Labcorp’s Executive Vice President and President, Diagnostics and Chief Operations Officer since 2023. In this role, Mark leads all Diagnostics divisions and commercial teams, as well as routine and esoteric testing laboratory operations for Labcorp Diagnostics and

Amy Summy has served as EVP, Chief Marketing Officer and Consumer Business Lead at Labcorp since March 2020. A member of Labcorp’s Executive Committee, Amy is responsible for global marketing including brand and reputation, ecommerce, customer experience, commercialization, product management,

Sandy van der Vaart has served as Executive Vice President, Chief Legal Officer and Corporate Secretary of Labcorp since February 2020. Prior to her current role with the company, Sandy served as Senior Vice President, Global General Counsel, Chief Compliance Officer and Corporate Secretary.

Bola Oyegunwa, Ph.D., has served as Labcorp’s Executive Vice President and Chief Information and Technology Officer since November 2024. Since joining Labcorp in 2019 as Vice President of Decentralized Clinical Trials Technology, Bola has pioneered advancements in remote clinical trial technology,

Julia Wang has served as Executive Vice President and Chief Financial Officer of Labcorp since December 2024. Prior to joining Labcorp, Julia served as CFO of BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235) since 2021, which she joined in 2020 as Senior Vice President, Enterprise Optimization and